Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

Dowiak.pdf (227.67 KB)

Document type

Conference object

Version

Published version

Publication date

2024-06-18

Publication license

cc-by-nc (c) Dowiak, Alexis et al., 2024
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/220114

ETMR-30. Clinical and molecular characterization of dicer-mutant central nervous system sarcoma

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1093/neuonc/noae064.200

Abstract

Central nervous system (CNS) sarcomas are rare mesenchymal non-meningothelial tumors accounting for 0.2% of brain tumors. Due to their rarity, there is a lack of substantive clinical, histological and molecular data.

Description

21st International Symposium on Pediatric Neuro-Oncology (ISPNO), International Society of Paediatric Oncology (SIOP), Filadèlfia, EEUU, 28 de juny - 2 juliol 2024

Subject

Sarcoma, Mutació (Biologia), Sistema nerviós central

Subject (English)

Sarcoma, Mutation (Biology), Central nervous system

Citation

Collections

Comunicacions a congressos (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citation

DOWIAK, Alexis, et al. ETMR-30. Clinical and molecular characterization of dicer-mutant central nervous system sarcoma. Neuro-Oncology. 2024. Vol. 26, num. 4, pags. iv58-iv59. ISSN 1523-5866. [consulted: 13 of August of 2026]. Available at: https://hdl.handle.net/2445/220114

Export metadata

JSON - METS

Share record